Is ARWR Worth Buying in 2026?

Arrowhead Research Corporation

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-07-26

Here’s whether Arrowhead Research Corporation (ARWR) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+0.36% over 10 days); RSI 49 — healthy momentum range; strong 1-year return of +426.4%; 3-month momentum positive (+15.8%). Currently 10.4% off its 52-week high. Score: +7/7.

Ready to act on this? 📈 Trade on Webull

ARWR is in a confirmed uptrend, trading above both its 50-day ($77.81) and 200-day ($63.95) moving averages. An RSI of 48.9 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +426.4% compares to +16.5% for SPY (beat the market by 410.0%).

$10,000 invested 1 year ago → $52,645 today
vs. S&P 500 (SPY) — same period beat market by 410.0%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($63.95)
Above 50-day MA ($77.81)
RSI(14) neutral zone (30–70) — currently 48.9
Positive return (+426.4%)
!Within 10% of period high (−10.4%)
Period Range $85.60
$15.01 $95.49
RSI (14) 48.9
0 · OversoldOverbought · 100

Key Metrics

Price$85.60
Period Return+426.4%
Period High$95.49
Period Low$15.01
Drawdown−10.4%
MA-50$77.81
MA-200$63.95
RSI (14)48.9
Avg Volume (30d)2.8M
vs. SPYbeat by 410.0%
Return Rank#11 of 999

Trade ARWR

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers